Orthofix Medical Inc., a medical device company, provides musculoskeletal healing products and therapies worldwide. More Details
Flawless balance sheet and fair value.
Share Price & News
How has Orthofix Medical's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: OFIX is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: OFIX's weekly volatility (6%) has been stable over the past year.
7 Day Return
US Medical Equipment
1 Year Return
US Medical Equipment
Return vs Industry: OFIX underperformed the US Medical Equipment industry which returned 18.4% over the past year.
Return vs Market: OFIX underperformed the US Market which returned 19% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Orthofix Medical's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 weeks ago | Simply Wall StOrthofix Medical Inc. Just Reported A Surprise Profit, And Analysts Lifted Their Estimates
1 month ago | Simply Wall StOrthofix Medical's (NASDAQ:OFIX) Shareholders Are Down 34% On Their Shares
1 month ago | Simply Wall StWhat Does Orthofix Medical Inc.'s (NASDAQ:OFIX) Share Price Indicate?
Is Orthofix Medical undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: OFIX ($38.67) is trading below our estimate of fair value ($47.98)
Significantly Below Fair Value: OFIX is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: OFIX is good value based on its PE Ratio (31.5x) compared to the US Medical Equipment industry average (48.5x).
PE vs Market: OFIX is poor value based on its PE Ratio (31.5x) compared to the US market (19.5x).
Price to Earnings Growth Ratio
PEG Ratio: OFIX is poor value based on its PEG Ratio (4.4x)
Price to Book Ratio
PB vs Industry: OFIX is good value based on its PB Ratio (2.1x) compared to the US Medical Equipment industry average (4.5x).
How is Orthofix Medical forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: OFIX's forecast earnings growth (7.1% per year) is above the savings rate (2.2%).
Earnings vs Market: OFIX's earnings (7.1% per year) are forecast to grow slower than the US market (21.9% per year).
High Growth Earnings: OFIX's earnings are forecast to grow, but not significantly.
Revenue vs Market: OFIX's revenue (7.8% per year) is forecast to grow slower than the US market (10.2% per year).
High Growth Revenue: OFIX's revenue (7.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: OFIX's Return on Equity is forecast to be low in 3 years time (5.9%).
How has Orthofix Medical performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: OFIX has a large one-off gain of $8.0M impacting its September 30 2020 financial results.
Growing Profit Margin: OFIX became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: OFIX has become profitable over the past 5 years, growing earnings by -14% per year.
Accelerating Growth: OFIX has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: OFIX has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (0.6%).
Return on Equity
High ROE: OFIX's Return on Equity (6.6%) is considered low.
How is Orthofix Medical's financial position?
Financial Position Analysis
Short Term Liabilities: OFIX's short term assets ($254.7M) exceed its short term liabilities ($93.4M).
Long Term Liabilities: OFIX's short term assets ($254.7M) exceed its long term liabilities ($68.9M).
Debt to Equity History and Analysis
Debt Level: OFIX is debt free.
Reducing Debt: OFIX had no debt 5 years ago.
Debt Coverage: OFIX has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: OFIX has no debt, therefore coverage of interest payments is not a concern.
What is Orthofix Medical current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate OFIX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate OFIX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if OFIX's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if OFIX's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of OFIX's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Jon Serbousek (59 yo)
Mr. Jon C. Serbousek serves as President and Chief Executive Officer at Orthofix Medical Inc., since November 1, 2019 and served as its President of Global Spine since August 5, 2019 until November 1, 2019...
CEO Compensation Analysis
Compensation vs Market: Jon's total compensation ($USD5.28M) is above average for companies of similar size in the US market ($USD2.59M).
Compensation vs Earnings: Insufficient data to compare Jon's compensation with company performance.
|CFO & Chief Accounting Officer||5.58yrs||US$1.90m||0.23% |
|Chief Legal & Administrative Officer||3.08yrs||US$1.81m||0.089% |
|Chief Scientific Officer||7.33yrs||no data||no data|
|Chief Information Officer||3.83yrs||no data||no data|
|Vice President of Investor Relations||no data||no data||no data|
|Chief Ethics & Compliance Officer||4.33yrs||no data||no data|
|President of Global Spine Business||0.92yr||no data||no data|
|President of Global Extremities||0.17yr||no data||no data|
|Senior Director of Business Development & Investor Relations||no data||no data||no data|
Experienced Management: OFIX's management team is considered experienced (3.1 years average tenure).
|Independent Chairman||6.67yrs||US$485.02k||0.68% |
|Independent Director||5.42yrs||US$250.56k||0.057% |
|Independent Director||6.58yrs||US$274.98k||0.14% |
|Independent Director||3.92yrs||US$259.98k||0.0067% |
|Independent Director||0.42yr||no data||no data|
|Independent Director||2.67yrs||US$244.98k||0% |
|Independent Director||8yrs||US$254.98k||0.14% |
|Independent Director||4.67yrs||US$279.98k||0.026% |
Experienced Board: OFIX's board of directors are considered experienced (4.7 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Orthofix Medical Inc.'s company bio, employee growth, exchange listings and data sources
- Name: Orthofix Medical Inc.
- Ticker: OFIX
- Exchange: NasdaqGS
- Founded: 1987
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: US$747.634m
- Shares outstanding: 19.33m
- Website: https://www.orthofix.com
Number of Employees
- Orthofix Medical Inc.
- 3451 Plano Parkway
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|OFIX||NasdaqGS (Nasdaq Global Select)||Yes||Common Shares||US||USD||Apr 1992|
|OM2||DB (Deutsche Boerse AG)||Yes||Common Shares||DE||EUR||Apr 1992|
Orthofix Medical Inc., a medical device company, provides musculoskeletal healing products and therapies worldwide. It operates through two segments, Global Spine and Global Extremities. The Global Spine s...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/11/24 23:49|
|End of Day Share Price||2020/11/24 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.